China: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Pharma Remains An Enforcement Focus In China – SAMR Orders Unwinding Of A Completed Pharma Deal

Recent years have seen regulator focus on the pharmaceutical sector in China intensify and enforcement has become a key priority. A recent decision by the China's State Administration...

China Healthcare

KL

Herbert Smith Freehills Kramer LLP

Industry Observation｜China Life Sciences And Healthcare Weekly Report No. 30

为进一步完善全链条支持创新药发展举措，推动创新药高质量发展，更好满足人民群众多元化就医用药需求，国家医保局、国家卫生健康委联

China Healthcare

SG

SGLA Law Firm

Six Key Insights Into China Biotech's NewCo Model

In the age of globalization, Chinese pharmaceutical companies are at the forefront of innovation and collaboration, seizing unprecedented development opportunities.

China Healthcare

HK

Han Kun Law Offices

What Are The Contract Essentials For China-related Life Sciences Collaboration Agreements?

China is becoming an increasing focus for transactions in the pharmaceuticals sector with its growing investment into research and development, government support and a steady...

Worldwide Healthcare

GW

Gowling WLG

China On The Move: China's Healthcare And Life Sciences Regulatory Evolution In 2025

China Healthcare

GT

Greenberg Traurig, LLP

The Regulatory Data Protection Regime In China (Draft For Comments)

China Healthcare

FP

Fangda Partners

China Compliance Update: Life Sciences — Summer 2025

China Healthcare

AP

Arnold & Porter

Growth and Opportunities in China's Medical Device Market.

China Healthcare

A

Acclime

试管婴儿辅助生殖行业法律问题探究

China Healthcare

AB

AnJie Broad Law Firm

China Advances Pharmaceutical Data Protection Regime With New Draft Measures

China Healthcare

AO

A&O Shearman

China Introduces A New Regulatory Data Protection And Exclusivity Mechanism

China Healthcare

AP

Arnold & Porter

Interpretation Of The Anti-Monopoly Guidelines For Pharmaceutical Sector: Key Risk Considerations

China Healthcare

AB

AnJie Broad Law Firm

揭秘中国创新药企NewCo模式实战中的"六脉神剑"

China Healthcare

HK

Han Kun Law Offices

CN 2025 Drafts On Clinical Trial Data Exclusivity

China Healthcare

TM

Toby Mak

Cayman Short Form Merger – Is It A Loophole?

Worldwide Commercial

A

Appleby

高温天气劳动保护相关法律问题问答

China Employment

AB

AnJie Broad Law Firm

《实施〈中华人民共和国反外国制裁法〉的规定》要点解读和实务建议

China International

SY

Shanghai YaoWang Law Offices

China's New Labor Rules: Key Provisions, Corporate Impacts, And Compliance Strategies

China Employment

LO

Llinks Law Offices

《反不正当竞争法》最新修订！对商标权保护有什么影响？

K

Kangxin

See more

Food and Drugs Law

Pharma Remains An Enforcement Focus In China – SAMR Orders Unwinding Of A Completed Pharma Deal

Recent years have seen regulator focus on the pharmaceutical sector in China intensify and enforcement has become a key priority. A recent decision by the China's State Administration...

China Healthcare

KL

Herbert Smith Freehills Kramer LLP

China's First Unwinding Order: SAMR Blocks Completed Below-Threshold Pharma Deal

On 23 July 2025, China's State Administration for Market Regulation (SAMR) issued a prohibition decision against Wuhan Yongtong Pharmaceutical's (YT Pharma) acquisition of Shandong...

China Anti-trust

KL

Herbert Smith Freehills Kramer LLP

Six Key Insights Into China Biotech's NewCo Model

In the age of globalization, Chinese pharmaceutical companies are at the forefront of innovation and collaboration, seizing unprecedented development opportunities.

China Healthcare

HK

Han Kun Law Offices

Determination Of "Related Patents" In Article 76(1) Of The Patent Law; The Way For Generic Drugs Applicants To Make A Declaration When The Product Only Differs From The Registered Original Drugs In Specifications

AC

AFD China

Adjudication Of Drug Patent Linkage Cases When The Originator Drug's Technical Solution Falls Outside The Protection Scope Of Patent Claims

AC

AFD China

The Trends Shaping Chinese Pharma Patent Litigation

L

Lusheng Law Firm

What Are The Contract Essentials For China-related Life Sciences Collaboration Agreements?

Worldwide Healthcare

GW

Gowling WLG

Draft For Soliciting Opinions On The Anti-Monopoly Guidelines In The Pharmaceutical Sector Released: Key Highlights For Pharmaceutical Companies

China Anti-trust

CB

Chance Bridge Law Firm

药品领域反垄断指南征求意见稿出台，有哪些亮点值得医药企业关注？

China Anti-trust

CB

Chance Bridge Law Firm

See more

Life Sciences, Biotechnology & Nanotechnology

Industry Observation｜China Life Sciences And Healthcare Weekly Report No. 30

为进一步完善全链条支持创新药发展举措，推动创新药高质量发展，更好满足人民群众多元化就医用药需求，国家医保局、国家卫生健康委联

China Healthcare

SG

SGLA Law Firm

Six Key Insights Into China Biotech's NewCo Model

In the age of globalization, Chinese pharmaceutical companies are at the forefront of innovation and collaboration, seizing unprecedented development opportunities.

China Healthcare

HK

Han Kun Law Offices

What Are The Contract Essentials For China-related Life Sciences Collaboration Agreements?

China is becoming an increasing focus for transactions in the pharmaceuticals sector with its growing investment into research and development, government support and a steady...

Worldwide Healthcare

GW

Gowling WLG

China On The Move: China's Healthcare And Life Sciences Regulatory Evolution In 2025

China Healthcare

GT

Greenberg Traurig, LLP

China Compliance Update – Summer 2025

AP

Arnold & Porter

A Brief Discussion On Biological Preservation And The Patentability Of Patent Applications Under Chinese Patent Law

K

Kangxin

The Regulatory Data Protection Regime In China (Draft For Comments)

China Healthcare

FP

Fangda Partners

Growth and Opportunities in China's Medical Device Market.

China Healthcare

A

Acclime

揭秘中国创新药企NewCo模式实战中的"六脉神剑"

China Healthcare

HK

Han Kun Law Offices

See more

Healthcare

Pharma Remains An Enforcement Focus In China – SAMR Orders Unwinding Of A Completed Pharma Deal

Recent years have seen regulator focus on the pharmaceutical sector in China intensify and enforcement has become a key priority. A recent decision by the China's State Administration...

China Healthcare

KL

Herbert Smith Freehills Kramer LLP

Industry Observation｜China Life Sciences And Healthcare Weekly Report No. 30

为进一步完善全链条支持创新药发展举措，推动创新药高质量发展，更好满足人民群众多元化就医用药需求，国家医保局、国家卫生健康委联

China Healthcare

SG

SGLA Law Firm

What Are The Contract Essentials For China-related Life Sciences Collaboration Agreements?

China is becoming an increasing focus for transactions in the pharmaceuticals sector with its growing investment into research and development, government support and a steady...

Worldwide Healthcare

GW

Gowling WLG

China On The Move: China's Healthcare And Life Sciences Regulatory Evolution In 2025

China Healthcare

GT

Greenberg Traurig, LLP

China Compliance Update – Summer 2025

AP

Arnold & Porter

The Regulatory Data Protection Regime In China (Draft For Comments)

China Healthcare

FP

Fangda Partners

China Compliance Update: Life Sciences — Summer 2025

China Healthcare

AP

Arnold & Porter

Growth and Opportunities in China's Medical Device Market.

China Healthcare

A

Acclime

中国创新药械全球崛起法律保障系列文章之一：创新药研发企业临床试验数据对外跨境传输的监管要点

AB

AnJie Broad Law Firm

See more

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More